Couple suing OptumRx over son's death, alleging his asthma meds rose by almost $500
A Wisconsin couple are suing Walgreens and Optum Rx over their son's death, claiming he was unable to afford a sudden spike of cost in his asthma medication. The suit was submitted in federal court by William and Shanon Schmidtknecht of Poynette, Wis. on Jan. 21, a year to the date that their son, 22-year-old Cole Schmidtknecht, died.
Wisconsin couple sues Walgreens, Optum Rx, saying son died after sudden $500 price spike for asthma meds
Shanon and William Schmidtknecht, of Poynette, say their 22-year-old son Cole was told the cost had jumped from $66 to $539 out-of-pocket. He tried to manage his condition with his rescue inhaler but suffered a fatal asthma attack days later.
Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase. Two weeks ...
Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase its ...
GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...
1don MSN
Arizona Attorney General Kris Mayes announced Thursday her office was suing a pharmaceutical company for alleged "deceptive" ...
The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.
Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...
Figuring out how your genes and environment increase your likelihood of developing asthma, heart disease, cancer, dementia ...
Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback